PHACTR4
Basic information
Region (hg38): 1:28369581-28500364
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHACTR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 29 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 30 | 3 | 0 |
Variants in PHACTR4
This is a list of pathogenic ClinVar variants found in the PHACTR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-28438421-G-A | not specified | Uncertain significance (Jul 08, 2022) | ||
1-28459110-G-T | not specified | Likely benign (Nov 28, 2023) | ||
1-28459156-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
1-28459159-A-C | not specified | Uncertain significance (Jun 23, 2023) | ||
1-28459169-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
1-28459189-G-T | not specified | Uncertain significance (Jan 23, 2023) | ||
1-28459219-A-G | not specified | Uncertain significance (Jan 18, 2022) | ||
1-28460220-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
1-28465697-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
1-28465727-A-G | not specified | Uncertain significance (Jun 11, 2021) | ||
1-28465769-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
1-28466466-C-T | not specified | Uncertain significance (Jan 31, 2024) | ||
1-28466543-A-C | not specified | Uncertain significance (Jul 14, 2021) | ||
1-28466558-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
1-28466690-C-G | not specified | Uncertain significance (Mar 29, 2024) | ||
1-28466738-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
1-28466745-A-T | not specified | Uncertain significance (Oct 27, 2022) | ||
1-28473556-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
1-28473578-G-C | not specified | Uncertain significance (Jul 13, 2022) | ||
1-28473598-C-G | not specified | Uncertain significance (Nov 12, 2021) | ||
1-28473599-C-T | not specified | Uncertain significance (Feb 11, 2022) | ||
1-28473607-C-A | not specified | Uncertain significance (Jul 13, 2022) | ||
1-28473629-T-C | not specified | Uncertain significance (Mar 07, 2023) | ||
1-28473710-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
1-28473718-A-G | not specified | Likely benign (Mar 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHACTR4 | protein_coding | protein_coding | ENST00000373836 | 13 | 130768 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000284 | 0.999 | 124775 | 1 | 34 | 124810 | 0.000140 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.10 | 334 | 396 | 0.844 | 0.0000212 | 4635 |
Missense in Polyphen | 103 | 137.67 | 0.74814 | 1599 | ||
Synonymous | 0.987 | 126 | 141 | 0.894 | 0.00000750 | 1429 |
Loss of Function | 2.97 | 15 | 33.5 | 0.447 | 0.00000202 | 387 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000285 | 0.000285 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000168 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.000164 | 0.000131 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of protein phosphatase 1 (PP1) required for neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. Acts as an activator of PP1 by interacting with PPP1CA and preventing phosphorylation of PPP1CA at 'Thr-320'. During neural tube closure, localizes to the ventral neural tube and activates PP1, leading to down-regulate cell proliferation within cranial neural tissue and the neural retina. Also acts as a regulator of migration of enteric neural crest cells (ENCCs) by activating PP1, leading to dephosphorylation and subsequent activation of cofilin (COF1 or COF2) and repression of the integrin signaling through the RHO/ROCK pathway (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0662
Intolerance Scores
- loftool
- 0.862
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.53
Haploinsufficiency Scores
- pHI
- 0.0406
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.202
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phactr4
- Phenotype
- cellular phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- neural crest cell migration;neural tube closure;Rho protein signal transduction;actin cytoskeleton organization;positive regulation of catalytic activity;regulation of phosphoprotein phosphatase activity;enteric nervous system development;regulation of cell cycle;closure of optic fissure;negative regulation of integrin-mediated signaling pathway
- Cellular component
- cytoplasm;lamellipodium
- Molecular function
- actin binding;protein phosphatase 1 binding;protein phosphatase activator activity